Evidence map›Paper›PMID 31128378›Full record

ArticleThe journal of allergy and clinical immunology. In practice

Carbonic anhydrase inhibitor-induced Stevens-Johnson syndrome/toxic epidermal necrolysis leads to extensive cutaneous involvement.

Sujeong Kim, James Yun, Dong Yoon Kang, Hye-Jung Park, Eun-Jung Jo, Jae-Woo Jung, Hye-Kyung Park, Jung-Won Park, Young-Koo Jee, Hye-Ryun Kang and 1 more

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in The journal of allergy and clinical immunology. In practice. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Sujeong KimDepartment of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Korea.
James YunFaculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia; Division of Medicine, Nepean Hospital, Sydney, New South Wales, Australia.
Dong Yoon KangDrug Safety Monitoring Center, Seoul National University Hospital, Seoul, Korea.
Hye-Jung ParkDepartment of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Eun-Jung JoDepartment of Internal Medicine, Pusan National University School of Medicine, Pusan, Korea.
Jae-Woo JungDepartment of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
Hye-Kyung ParkDepartment of Internal Medicine, Pusan National University School of Medicine, Pusan, Korea.
Jung-Won ParkDepartment of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.
Young-Koo JeeDepartment of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea.
Hye-Ryun KangDrug Safety Monitoring Center, Seoul National University Hospital, Seoul, Korea; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea. Electronic address: helenmed@snu.ac.kr.
Jong-Myung LeeDepartment of Internal Medicine, School of Medicine, Kyungpook National University, Kyungpook National University Hospital, Daegu, Korea. Electronic address: jomlee@knu.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AcetazolamideAdultAgedCarbonic Anhydrase InhibitorsFemaleHumansMaleMethazolamideMiddle AgedSeverity of Illness IndexStevens-Johnson SyndromeAcetazolamideCarbonic Anhydrase InhibitorsMethazolamide

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.